InvestorsHub Logo
Followers 4
Posts 172
Boards Moderated 0
Alias Born 03/02/2015

Re: None

Tuesday, 09/13/2022 9:34:08 AM

Tuesday, September 13, 2022 9:34:08 AM

Post# of 973
OTLK - UPDATE: Chardan Capital analyst Daniil Gataulin initiates coverage on Outlook Therapeutics (NASDAQ:OTLK) with a Buy rating and announces Price Target of $10

Benzinga · 09/13/2022 06:06

SOURCE:
https://www.webull.com/news/7297859645928448
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent OTLK News